Inventor · disambiguated record
James Rusnak
Also filed as: RUSNAK JAMES · RUSNAK JAMES M · RUSNAK JAMES MICHAEL
7 granted patents·4 pending applications·90 citations·filing 2004–2020
82Inventor score
Top patents by PatentIndex Score
11 records- 0193US7307064B2Methods for treating cardiovascular disease using a soluble CTLA4 moleculeBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Dec 11, 2007·61 cites·18 claims
- 0291US7482327B2Methods for treating immune disorders associated with graft transplantation with soluble CTLA4 mutant moleculesBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Jan 27, 2009·23 cites·25 claims
- 0384US7671022B2Methods for treating cardiovascular disease using a soluble CTLA4 moleculeBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Mar 2, 2010·6 cites·16 claims
- 0464US10709684B2SGLT-2 inhibitors for treating metabolic disorders in patients with renal impairment or chronic kidney diseaseMERCK SHARP & DOHME·Filed 2019·Granted Jul 14, 2020·0 cites·11 claims
- 0563US2020297692A1Sglt-2 inhibitors for treating metabolic disorders in patients with renal impairment or chronic kidney diseaseMERCK SHARP & DOHME·Filed 2020·Application pending·0 cites
- 0661US10500186B2SGLT-2 inhibitors for treating metabolic disorders in patients with renal impairment or chronic kidney diseaseMERCK SHARP & DOHME·Filed 2019·Granted Dec 10, 2019·0 cites·4 claims
- 0757US2009041790A1Methods for treating cardiovascular disease using a soluble CTLA4 moleculeBRISTOL MYERS SQUIBB CO·Filed 2007·Application pending·0 cites
- 0857US2010041602A1Methods for treating immune disorders associated with graft transplantation with soluble CTLA4 mutant moleculesBRISTOL MYERS SQUIBB CO·Filed 2008·Application pending·0 cites
- 0952US10285973B2SGLT-2 inhibitors for treating metabolic disorders in patients with renal impairment or chronic kidney diseaseMERCK SHARP & DOHME·Filed 2015·Granted May 14, 2019·0 cites·13 claims
- 1049US12036203B2Methods of treating or reducing the risk of cardiovascular events and related diseases using SGLT-2 inhibitorsMERCK SHARP & DOHME LLC·Filed 2019·Granted Jul 16, 2024·0 cites·4 claims
- 1145US2019076395A1Methods of treating or reducing the risk of cardiovascular events and related diseases using sglt-2 inhibitorsMERCK SHARP & DOHME·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when James Rusnak files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →